American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,716 | 59,204 | 52,892 | 83,673 | 76,337 |
| Receivables | 46,987 | 54,300 | 71,350 | 103,950 | 61,582 |
| Inventories | 24,453 | 28,553 | 18,890 | 24,201 | 24,563 |
| Income taxes - deferred | 3,198 | 3,247 | 3,226 | 221 | 319 |
| Other current assets | 24,955 | 27,786 | 49,553 | 21,388 | 20,906 |
| TOTAL | $151,308 | $173,090 | $195,911 | $233,433 | $183,707 |
| Non-Current Assets | |||||
| PPE Net | 176,367 | 171,506 | 170,535 | 136,405 | 110,061 |
| Investments And Advances | 4,442 | 5,695 | 5,934 | 18,922 | 61,532 |
| Intangibles | 171,257 | 168,460 | 168,657 | 203,915 | 203,949 |
| Other Non-Current Assets | 27,084 | 31,117 | 23,945 | 46,325 | 71,578 |
| TOTAL | $379,150 | $376,777 | $369,071 | $405,568 | $447,119 |
| Total Assets | $530,457 | $549,867 | $564,981 | $639,001 | $630,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,626 | 3,663 | 63 | 63 | 62 |
| Accounts payable and accrued liabilities | 22,666 | 23,343 | 43,287 | 29,292 | 28,839 |
| Accrued Expenses | 27,169 | 26,191 | 8,849 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 5,161 | 4,108 |
| TOTAL | $172,829 | $168,560 | $168,628 | $48,870 | $45,203 |
| Non-Current Liabilities | |||||
| Long Term Debt | 587 | 602 | 618 | 632 | 649 |
| Other Non-Current Liabilities | -19 | 30 | 1,027 | 117,403 | 121,655 |
| TOTAL | $15,277 | $15,287 | $15,191 | $132,270 | $137,987 |
| Total Liabilities | $188,105 | $183,846 | $183,819 | $181,139 | $183,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73 | 73 | 73 | 79 | 78 |
| Common Shares | 466 | 424 | 370 | 303 | 236 |
| Retained earnings | 94,867 | 120,654 | 137,811 | 216,442 | 212,020 |
| Other shareholders' equity | 41,365 | 39,680 | 37,388 | 36,143 | 31,229 |
| TOTAL | $342,352 | $366,021 | $381,162 | $457,861 | $447,636 |
| Total Liabilities And Equity | $530,457 | $549,867 | $564,981 | $639,001 | $630,826 |